| CENP-F (Centromere protein F, CENPF, centromere protein F (350/400kD, mitosin), CENF, PRO1779, mitosin, AH antigen, CENP-F kinetochore protein, centromere protein F (400kD), cell-cycle-dependent 350K nuclear protein) |
674€ |
View |
| CENP-F (Centromere protein F, CENPF, centromere protein F (350/400kD, mitosin), CENF, PRO1779, mitosin, AH antigen, CENP-F kinetochore protein, centromere protein F (400kD), cell-cycle-dependent 350K nuclear protein)[CENP-F] |
5€ |
View |
| CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) |
569€ |
View |
| CEP290 (NPHP6, CEP290, Centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) |
669€ |
View |
| CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (Control Peptide) |
492€ |
View |
| CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (Control Peptide)[CEP290] |
5€ |
View |
| CEP290 (NPHP6, CEP290, Centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2)[CEP290] |
5€ |
View |
| CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2)[CEP290] |
5€ |
View |
| Ceruloplasmin Antigen >=95% |
475€ |
View |
| Ceruloplasmin Antigen >=95%[Ceruloplasmin] |
5€ |
View |